1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Global Mental Health Analysis & Statistics, May 2019

Global Mental Health Analysis & Statistics, May 2019

1-30 of about 800 reports

Healthcare Services Global Market Opportunities And Strategies To 2022

Healthcare Services Global Market Opportunities And Strategies To 2022

  • $ 8000
  • Industry report
  • April 2019

Healthcare Services Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global healthcare ...

  • Industries : Health Services, Healthcare
  • Countries : World
Biomarkers in the Central Nervous System

Biomarkers in the Central Nervous System

  • $ 7995
  • Industry report
  • April 2019

Biomarkers in the Central Nervous SystemSummaryFinding a biomarker for Central Nervous System (CNS) disorders that translates into clinical meaningfulness has been a real challenge for the biomarkers ...

  • Industries : Genomics Proteomics and Enabling Technology, Mental Health, Biotechnology, Pathology
  • Countries : World, United States
Neurophotonics: Global Markets and Technologies to 2023

Neurophotonics: Global Markets and Technologies to 2023

  • $ 5500
  • Industry report
  • April 2019

Report Scope:This report provides an updated review of neurophotonics technologies, including a description of various devices, and identifies current and emerging technologies used in different neurology ...

  • Industries : Mental Health
  • Countries : World
Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product ; Disease ; End User and Geography

Interventional Neuroradiology Market to 2027- Global Analysis and Forecasts by Product ; Disease ; End User and Geography

  • $ 4550
  • Industry report
  • May 2019

The global interventional neuroradiology market is expected to reach US$ 3,254.55 Mn in 2027 from US$ 1,969.39 Mn in 2018. The market is estimated to grow with a CAGR of 5.9% from 2019-2027.Progressive ...

  • Industries : Health Services, Healthcare, Pathology
  • Countries : World
Nurse Call Systems Market to 2027 - Global Analysis and Forecasts By Equipment, Technology, Application, End User and Geography

Nurse Call Systems Market to 2027 - Global Analysis and Forecasts By Equipment, Technology, Application, End User and Geography

  • $ 4550
  • Industry report
  • April 2019

The global nurse call systems market is expected to reach US$ 2,936.83 Mn in 2027 from US$ 1,252.65 Mn in 2018. The market is estimated to grow with a CAGR of 10.3% from 2019-2027.The growth of the nurse ...

  • Industries : Healthcare, Health Services
  • Countries : World, North America
Narcolepsy Market to 2027- Global Analysis and Forecasts by Type; Product; Distribution Channel and Geography

Narcolepsy Market to 2027- Global Analysis and Forecasts by Type; Product; Distribution Channel and Geography

  • $ 4550
  • Industry report
  • February 2019

The global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018. The market is estimated to grow with a CAGR of 9.5% from 2019-2027.The growth of the narcolepsy market ...

  • Industries : Mental Health, Pathology
  • Countries : World, North America
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

  • $ 4499
  • Industry report
  • March 2019

INTRODUCTIONChronic disorders, such as diabetes, cancer, heart disease, obesity, and certain types of mental health problems, are considered among the leading causes of death and disability across the ...

  • Industries : Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pathology, Therapy
  • Countries : United States, North America, World
Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023

Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023

  • $ 4450
  • Industry report
  • March 2019

Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023Amyotrophic Lateral Sclerosis Market Research Report: By Type (Familial ALS), by Treatment (Medication, Physical Therapy, Speech ...

  • Industries : Mental Health, Pharmaceutical, Therapy, Pathology
  • Countries : United States, North America, World
Global Myasthenia Gravis Market Research Report Forecast to 2023

Global Myasthenia Gravis Market Research Report Forecast to 2023

  • $ 4450
  • Industry report
  • March 2019

Myasthenia Gravis Market: By Type (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis, Transient Myasthenia Gravis, and Others), (Diagnosis and Treatment), End User (Hospitals ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, North America
Parkinson’s Disease Drugs Market - Growth, Trends, and Forecast (2019-2024)

Parkinson’s Disease Drugs Market - Growth, Trends, and Forecast (2019-2024)

  • $ 4250
  • Industry report
  • April 2019

Market OverviewParkinson’s disease is a chronic disorder that gradually leads to progressive deterioration of motor functions, caused by the loss of dopamine-producing brain cells. Parkinson’s disease ...

  • Industries : Mental Health, Pathology
  • Countries : United States, North America, World
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, United States
Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) pipeline Target constitutes close to 23 molecules. Out of which approximately ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Survival Motor Neuron Protein - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Mental Health
  • Countries : United States, World
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019SummaryIntegrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha o ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : World, United States
P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2019SummaryP2X Purinoceptor 7 (P2Z Receptor or P2RX7) - P2X purinoceptor 7 is a protein encoded by the P2RX7 gene. It acts as receptor fo ...

  • Industries : Pharmaceutical, Therapy, Pathology
  • Countries : World
Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Sodium And Chloride Dependent Glycine Transporter 1 (Glyt1 or Solute Carrier Family 6 Member 9 or SLC6A9) - Pipeline Review, H1 2019SummarySodium And Chloride Dependent Glycine Transporter 1 (Glyt1 o ...

  • Industries : Mental Health
  • Countries : World
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : Switzerland, World, United States
Global Psychiatry Partnering 2014-2019: Deal trends, players and financials

Global Psychiatry Partnering 2014-2019: Deal trends, players and financials

  • $ 2995
  • Industry report
  • March 2019

Global Psychiatry Partnering 2014 to 2019 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.Trends in Psychiatry ...

  • Industries : Mental Health, Pathology
  • Countries : World
Global Attention deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023

Global Attention deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023

  • $ 2500
  • Industry report
  • May 2019

About this marketThe rising incidence rate of ADHD among children is one of the critical factors that will trigger the growth of the attention deficit hyperactivity disorder drugs market. The expansion ...

  • Industries : Mental Health
  • Countries : World
Global Medical Cannabis Market - Opportunities and Forecast (2014-2024)

Global Medical Cannabis Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • Industry report
  • March 2019

Executive SummaryA comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Industries : Recreational Activity, Marijuana, Marijuana, Consumer Goods
  • Countries : World
Global Central Nervous System Therapeutic Market - Opportunities and Forecast (2014-2024)

Global Central Nervous System Therapeutic Market - Opportunities and Forecast (2014-2024)

  • $ 2200
  • Industry report
  • March 2019

Executive SummaryA comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Industries : Health Services, Healthcare
  • Countries : World
2019 Lower Limb Muscle Spasticity Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Lower Limb Muscle Spasticity Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Lower Limb Muscle Spasticity Ongoing Clinical Trials Study” analyzes the current scenario of all active Lower Limb Muscle Spasticity trials across ...

  • Industries : Health Services, Mental Health, Drug Development, Pathology
  • Countries : APAC
2019 Metachromatic Leukodystrophy (MLD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Metachromatic Leukodystrophy (MLD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Metachromatic Leukodystrophy (MLD) Ongoing Clinical Trials Study” analyzes the current scenario of all active Metachromatic Leukodystrophy (MLD) trials ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC
2019 Mild Cognitive Impairment Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Mild Cognitive Impairment Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Mild Cognitive Impairment Ongoing Clinical Trials Study” analyzes the current scenario of all active Mild Cognitive Impairment trials across the world. ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC
2019 Hepatic Encephalopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Hepatic Encephalopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Hepatic Encephalopathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Hepatic Encephalopathy trials across the world. The ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC
2019 Multiple Sclerosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Multiple Sclerosis Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Multiple Sclerosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Multiple Sclerosis trials across the world. The report ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC
2019 Hypersomnia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Hypersomnia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Hypersomnia Ongoing Clinical Trials Study” analyzes the current scenario of all active Hypersomnia trials across the world. The report presents top ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC, World
2019 Lennox-Gastaut Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Lennox-Gastaut Syndrome Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Lennox-Gastaut Syndrome Ongoing Clinical Trials Study” analyzes the current scenario of all active Lennox-Gastaut Syndrome trials across the world. ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC
2019 Hypoxic-Ischemic Encephalopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

2019 Hypoxic-Ischemic Encephalopathy Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

  • $ 2199
  • Industry report
  • February 2019

The ongoing clinical trial research report- “2019 Hypoxic-Ischemic Encephalopathy Ongoing Clinical Trials Study” analyzes the current scenario of all active Hypoxic-Ischemic Encephalopathy trials across ...

  • Industries : Drug Development, Mental Health
  • Countries : APAC

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on